December 02, 2022
A Closing Thought
31
12
Regulations that apply across geographic borders can provide researchers and patients a firmer foundation on data protection.
December 02, 2022
Feature Articles
31
12
A roadmap to avoiding the common pitfalls of concurrent FDA-EMA filings.
December 02, 2022
Feature Articles
31
12
Summarizing important FDA and EMA revisions issued this year.
December 02, 2022
Feature Articles
31
12
Navigating FDA’s draft guidance and heightened diversity recommendations.
December 02, 2022
Data Collection
31
12
Final presentation at DIA reminds: "we are all patients."
December 02, 2022
RBQM
31
12
Study indentifies trends in most commonly used KRIs.
December 02, 2022
Q&A
31
12
Nabil Chehab, medical affairs head of lung cancer franchise at AstraZeneca, discuss strategies used in the Phase III AEGEAN trial for treating non-small lung cancer (NSCLC).
December 02, 2022
View from Brussels
31
12
Debates caught between focusing on existing antibiotics and developing new agents.
December 02, 2022
View from Washington
31
12
Looking back on major FDA moves in 2022.
December 02, 2022
From the Editor
31
12
Industry straddling two worlds as new year approaches.
December 02, 2022
Issue PDF
31
12
Click the title above for a link to open the Applied Clinical Trials December 2022 issue in an interactive PDF format.